Humira could generate more than $20 billion in sales for AbbVie during 2021 while Merck’s Keytruda is on track to become only the second prescription medicine ever to exceed $16 billion in annual sales.
With more than half of the U.S. population fully vaccinated and mask mandates being lifted throughout the country, America looks to resume “normal life” before the pandemic took over.
Last year challenged biotech and pharma companies to explore what is possible. When several companies can develop COVID-19 vaccines at a record pace, it proves that the industry is capable of massive feats.
Galectin Therapeutics is one of the only biotech companies with an active Phase IIb/III clinical trial for NASH cirrhosis. Galectin recently launched a site dedicated to its study, NAVIGATE: https://navigatenash.com/. Also, the Journal for ImmunoTherapy of Cancer recently published Phase I clinical research showing belapectin, Galectin Therapeutics’ galectin-3 inhibitor, enhances tumor response in combination with anti-PD-1 therapy. Med Ad News discussed these and other topics with Dr. Pol Boudes, CMO of Galectin.
CEO Usama Malik is leading an exciting period of growth for Fore Biotherapeutics as the company evolves as a leader in precision oncology with its unique business model and ability to deliver the right therapies to currently underserved patients.
Karmen Trzupek, MS, CGC, Director, Rare Disease Genetics and Clinical Trial Services at InformedDNA, talked to Med Ad News about an array of topics including the impact COVID-19 has had on clinical trials throughout the industry.
Med Ad News talked to Wendbush Securities analysts David Nierengarten, Laura Chico, and Liana Moussatos about various new drug approvals and other recent news updates in the industry.
Carmine Therapeutics Inc., an emerging leader in gene therapy, appointed Don Haut, Ph.D. as CEO and member of the board of directors.
Agencies and networks featured in Med Ad News’ 2021 Healthcare Communications Agencies Edition have kept client work going smoothly during the COVID-19 pandemic, and when it came to sustaining their own cultures, managed to rise to that challenge in unique ways. From Zoom coffees and cocktails, to ice cream deliveries, to art exhibits, to showing off the activities and things that kept them sane during lockdown, many healthcare ad agencies strove to extend their culture to everyone’s work-from-home situation.
At the corner of South Adams and Magnolia Avenue, in Fort Worth, Texas there is an advertising agency that knows the value of people, according to management. “From the patients who fill prescriptions and the surgeons who perform procedures to the people who sit behind the desks in our office (we affectionately call them squirrels) and those who make up the community we’re part of, we have always put people at the center of what we do.”